This episode will discuss the potential impacts that blood-based biomarkers have for the future of dementia diagnosis and care, from diagnostic blood tests for Alzheimer’s disease and improved early detection tools to potential new treatments.

George Perry, PhD
Professor & Semmes Foundation Distinguished University Chair in Neurobiology, University of Texas at San Antonio
Member, AFA Medical, Scientific, and Memory Screening Advisory Board

AFA Fireside Chat: What’s Next for Blood-Based Biomarkers?